Jackson, W., Suresh, K., Maurino, C., Feng, M., Cuneo, K., Ten Haken, R., . . . Owen, D. (2019). A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy. Radiother Oncol.

Jackson, W.C., K. Suresh, C. Maurino, M. Feng, K.C Cuneo, R.K Ten Haken, T.S Lawrence, M.J Schipper, and D. Owen. "A Mid-treatment Break and Reassessment Maintains Tumor Control and Reduces Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy." Radiother Oncol 2019.

Jackson, W.C., et al. "A Mid-treatment Break and Reassessment Maintains Tumor Control and Reduces Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy." Radiother Oncol 2019.